As well as its needed effects, isoniazid / pyrazinamide / rifampin may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking isoniazid / pyrazinamide / rifampin, check with your doctor immediately:
Some isoniazid / pyrazinamide / rifampin side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
This medicine commonly causes urine, stool, saliva, sputum, sweat, and tears to turn reddish-orange to reddish-brown. This side effect does not usually require medical attention.
Dark urine and yellowing of the eyes or skin (signs of liver problems) caused by isoniazid are more likely to occur in patients 50 years of age and older.
Frequency not reported: Altered levels of liver enzymes (SGOP, SGPT)Isoniazid: Frequency not reported: Elevated serum transaminases (SCOT, SCPT), bilirubinemia, bilirubinuria, jaundice, hepatitisPyrazinamide: Frequency not reported: Hepatotoxicity (e.g., hepatic cell function abnormality, liver tenderness, jaundice, acute yellow atrophy)Rifampin: Rare (less than 0.1%): Hepatitis, shock-like syndrome with hepatic involvementFrequency not reported: Abnormal liver function tests (e.g., elevations in serum bilirubin, alkaline phosphatase, serum transaminases), jaundice
Frequency not reported: Altered levels of serum uric acid levelsIsoniazid: Frequency not reported: Pyridoxine deficiency, pellagra, hyperglycemia, metabolic acidosisPyrazinamide: Frequency not reported: Hyperuricemia, gout, anorexia, porphyriaRifampin: Frequency not reported: Anorexia, elevated serum uric acid
Common (1% to 10%): Rash, erythroderma, erythema, exfoliative dermatitis, Lyell syndrome, urticaria, localized skin rash, diffuse skin rash, pruritus, sweatingIsoniazid:Frequency not reported: Stevens-Johnson syndrome, vasculitis, skin eruptions (morbilliform, maculopapular, purpuric, or exfoliative), rash, pemphigus, acnePyrazinamide: Rare (less than 0.1%): Acne, photosensitivityFrequency not reported: Rash, urticaria, pruritus, erythemaRifampin: Uncommon (0.1% to 1%): UrticariaRare (less than 0.1%): Exfoliate dermatitis, pemphigoid reaction, erythema multiforme (Stevens-Johnson syndrome, Lyells syndrome, vasculitis)Frequency not reported: Flushing, itching with or without a rash (mild, self-limiting), pruritus, rash, pemphigoid reaction, toxic epidermal necrolysis, vasculitis
Common (1% to 10%): Generalized hypersensitivityIsoniazid: Frequency not reported: Anaphylactic reactions Pyrazinamide: Rare (less than 0.1%): AngioedemaRifampin: Rare (less than 0.1%): Anaphylaxis
Common (1% to 10%): Headache, insomnia, diffuse paresthesia of the legs, anxiety, diabetic coma, tinnitus, vertigo, vertigo with loss of equilibriumIsoniazid: Uncommon (0.1% to 1%): Convulsions, toxic encephalopathy, optic neuritis and atrophy, memory impairmentFrequency not reported: Peripheral neuropathy, vertigo, polyneuritisRifampin: Frequency not reported: Cerebral hemorrhage, headache, drowsiness, ataxia, dizziness, inability to concentrate, generalized numbness
Common (1% to 10%): Coughing, hemoptysis, total pneumothoraxRifampin: Frequency not reported: Shortness of breath, wheezing
Common (1% to 10%): Chest tightness, diffuse chest pain, angina, palpitation, phlebitisRifampin: Frequency not reported: Blood pressure decrease, shock
Common (1% to 10%): Arthralgia, long bones pain, localized and diffuse joint pain, edema of the legsIsoniazid: Frequency not reported: Rheumatic syndrome, systemic lupus erythematosus-like syndromePyrazinamide: Frequency not reported: Mild arthralgia, myalgiaRifampin: Rare (less than 0.1%): MyopathyFrequency not reported: Muscular weakness, pain in extremities
Common (1% to 10%): Nausea, vomiting, digestive pain, diarrheaIsoniazid: Frequency not reported: Pancreatitis, nausea, vomiting, epigastric distress, constipation, dry mouthPyrazinamide: Frequency not reported: Nausea, vomiting, peptic ulcer aggravationRifampin: Frequency not reported: Heartburn, epigastric distress, nausea, vomiting, flatulence, cramps, diarrhea, pseudomembranous colitis, abdominal discomfort, sore mouth, sore tongue
Common (1% to 10%): Spiking fever, persistent feverIsoniazid: Frequency not reported: FeverPyrazinamide: Rare (less than 0.1%): Malaise, feverRifampin: Very common (10% or more): "Flu" syndrome (episodes of fever, chills, headache, dizziness, bone pain; up to 50%)Frequency not reported: Fatalities, fever, fatigue, edema of the face and extremities
Isoniazid: Frequency not reported: GynecomastiaRifampin: Rare (less than 0.1%): Adrenal insufficiencyFrequency not reported: Menstrual disturbances
Pyrazinamide: Frequency not reported: Dysuria
Isoniazid: Frequency not reported: Agranulocytosis, anemia (hemolytic, sideroblastic, aplastic), thrombocytopenia, eosinophiliaPyrazinamide: Rare (less than 0.1%): Thrombocytopenia with or without purpura, sideroblastic anemia with erythroid hyperplasia, vacuolation of erythrocytes, increased serum concentration, adverse effects on blood clotting mechanismsRifampin: Rare (less than 0.1%): Disseminated intravascular coagulation, agranulocytosis, hemolysis, hemoglobinuria, hematuriaFrequency not reported: Thrombocytopenia with or without purpura, leukopenia, hemolytic anemia, decreased hemoglobin, eosinophilia
Isoniazid: Frequency not reported: Anti-nuclear antibodies, lymphadenopathy
Isoniazid:Frequency not reported: Visual disordersRifampin: Frequency not reported: Visual disturbances, conjunctivitis
Pyrazinamide:Rare (less than 0.1%): Interstitial nephritisRifampin: Rare (less than 0.1%): Interstitial nephritis, acute tubular necrosis, renal insufficiency, acute renal failure Frequency not reported: Elevated BUN
Isoniazid: Uncommon (0.1% to 1%): Toxic psychosisRifampin: Rare (less than 0.1%): PsychosesFrequency not reported: Mental confusion, behavioral changes
It is possible that some side effects of Rifater may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Clumsiness or unsteadiness
dark urine
loss of appetite
nausea and vomiting
numbness, tingling, burning, or pain in the hands and feet
pain in large and small joints 
unusual tiredness or weakness
yellow eyes or skin
Chills
difficulty with breathing
dizziness
fever
headache
itching
muscle and bone pain
redness of the skin
shivering
skin rash
Bloody or cloudy urine
blurred vision or loss of vision, with or without eye pain
convulsions (seizures)
greatly decreased frequency of urination or amount of urine
mental depression
mood or mental changes
sore throat
unusual bleeding or bruising
Diarrhea
stomach pain
Sore mouth or tongue